Healthcare provider profile · identity verified

Daniel Canby

Family Practice · LARGO, FL · NPI 1942733274

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	440	141
Rosuvastatin Calcium	Rosuvastatin Calcium	273	96
Losartan Potassium	Losartan Potassium	258	85
Lisinopril	Lisinopril	257	84
Amlodipine Besylate	Amlodipine Besylate	240	83
Albuterol Sulfate Hfa	Albuterol Sulfate	237	102
Levothyroxine Sodium	Levothyroxine Sodium	230	76
Fluticasone Propionate	Fluticasone Propionate	201	117
Omeprazole	Omeprazole	172	64
Pantoprazole Sodium	Pantoprazole Sodium	169	72
Gabapentin	Gabapentin	166	53
Trazodone Hcl	Trazodone Hcl	165	68
Metformin Hcl	Metformin Hcl	159	57
Tamsulosin Hcl	Tamsulosin Hcl	156	59
Tramadol Hcl	Tramadol Hcl	138	49
Metoprolol Tartrate	Metoprolol Tartrate	136	46
Metoprolol Succinate	Metoprolol Succinate	131	45
Glipizide	Glipizide	125	44
Diclofenac Sodium	Diclofenac Sodium	119	79
Carvedilol	Carvedilol	110	39
Prednisone	Prednisone	109	75
Furosemide	Furosemide	97	47
Eliquis	Apixaban	92	28
Duloxetine Hcl	Duloxetine Hcl	89	33
Alprazolam	Alprazolam	85	28
Montelukast Sodium	Montelukast Sodium	84	33
Hydrochlorothiazide	Hydrochlorothiazide	83	29
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	80	36
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	77	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	27
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	73	63
Doxycycline Monohydrate	Doxycycline Monohydrate	71	51
Simvastatin	Simvastatin	71	29
Clopidogrel	Clopidogrel Bisulfate	65	30
Triamcinolone Acetonide	Triamcinolone Acetonide	64	48
Ibuprofen	Ibuprofen	63	31
Vitamin D2	Ergocalciferol (Vitamin D2)	61	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	16
Famotidine	Famotidine	56	29
Naproxen	Naproxen	56	37
Mirtazapine	Mirtazapine	55	24
Pregabalin	Pregabalin	55	22
Alendronate Sodium	Alendronate Sodium	53	23
Potassium Chloride	Potassium Chloride	53	23
Baclofen	Baclofen	51	25
Ezetimibe	Ezetimibe	50	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	49	37
Hydroxyzine Hcl	Hydroxyzine Hcl	46	23
Lorazepam	Lorazepam	46	suppressed
Meloxicam	Meloxicam	45	25
Oxybutynin Chloride Er	Oxybutynin Chloride	45	20
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	45	41
Finasteride	Finasteride	44	20
Spironolactone	Spironolactone	44	18
Warfarin Sodium	Warfarin Sodium	44	14
Jardiance	Empagliflozin	43	12
Sertraline Hcl	Sertraline Hcl	43	18
Tizanidine Hcl	Tizanidine Hcl	42	22
Celecoxib	Celecoxib	40	16
Glipizide Er	Glipizide	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	11
Metformin Hcl Er	Metformin Hcl	36	16
Pravastatin Sodium	Pravastatin Sodium	36	11
Sildenafil Citrate	Sildenafil Citrate	36	13
Nifedipine Er	Nifedipine	35	14
Ozempic	Semaglutide	35	suppressed
Methylprednisolone	Methylprednisolone	34	29
Nitroglycerin	Nitroglycerin	34	18
Xarelto	Rivaroxaban	34	suppressed
Azithromycin	Azithromycin	33	29
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	33	11
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	33	14
Escitalopram Oxalate	Escitalopram Oxalate	32	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	12
Allopurinol	Allopurinol	31	11
Bupropion Xl	Bupropion Hcl	30	14
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	13
Ciclopirox	Ciclopirox	28	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	11
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	11
Ondansetron Odt	Ondansetron	25	16
Levofloxacin	Levofloxacin	24	19
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	21	suppressed
Bumetanide	Bumetanide	21	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	13
Buspirone Hcl	Buspirone Hcl	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Sucralfate	Sucralfate	19	12
Fenofibrate	Fenofibrate	18	suppressed
Primidone	Primidone	18	suppressed
Temazepam	Temazepam	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Topiramate	Topiramate	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Lactulose	Lactulose	16	12
Meclizine Hcl	Meclizine Hcl	16	12
Atenolol	Atenolol	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Fluconazole	Fluconazole	15	15
Levetiracetam	Levetiracetam	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Methimazole	Methimazole	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Ceftriaxone	Ceftriaxone Sodium	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error